Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, Singh S, Mohamed EA, Abu Dabrh AM, Prokop LJ, Wang Z, Murad MH, Mohammed K.
Hepatology. 2016 Jan;63(1):284-306. doi: 10.1002/hep.28280. Epub 2015 Nov 13.
Viral hepatitis B: clinical and epidemiological characteristics.
Burns GS, Thompson AJ.
Cold Spring Harb Perspect Med. 2014 Oct 30;4(12):a024935. doi: 10.1101/cshperspect.a024935.
Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment.
Li J, Dong XQ, Cao LH, Zhang ZQ, Zhao WF, Shang QH, Zhang DZ, Ma AL, Xie Q, Gui HL, Zhang G, Liu YX, Shang J, Xie SB, Liu YQ, Zhang C, Wang GQ, Zhao H; China HepB Related Fibrosis Assessment Research Group.
Front Cell Infect Microbiol. 2023 Jun 16;13:1151899. doi: 10.3389/fcimb.2023.1151899. eCollection 2023.
Therapeutic vaccination for chronic hepatitis B.
Kosinska AD, Bauer T, Protzer U.
Curr Opin Virol. 2017 Apr;23:75-81. doi: 10.1016/j.coviro.2017.03.011. Epub 2017 Apr 25.
Etiologies of Persistent Aminotransferase Elevations in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs.
Xiong QF, Zou L, Chen ZJ, Liu HL, Lu YJ, Liu DX, Yang YF.
Turk J Gastroenterol. 2024 Feb 29;35(6):497-504. doi: 10.5152/tjg.2024.23512.
Circulating metabolites are associated with persistent elevations of ALT in patients with chronic hepatitis B with complete viral suppression.
Zheng D, Cheng C, Tang Y, Fang Z, Gao X, Chen Y, You Q, Wang K, Zhou H, Lan Z, Sun J.
J Med Virol. 2024 Jun;96(6):e29723. doi: 10.1002/jmv.29723.
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma.
Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, Xie Y, Li M.
Virulence. 2024 Dec;15(1):2421231. doi: 10.1080/21505594.2024.2421231. Epub 2024 Nov 20.
Staging Fibrosis in Chronic Viral Hepatitis.
Cardoso AC, Figueiredo-Mendes C, Villela-Nogueira CA, Marcellin P.
Viruses. 2022 Mar 23;14(4):660. doi: 10.3390/v14040660.
Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations.
Yuen MF, Ahn SH, Chen DS, Chen PJ, Dusheiko GM, Hou JL, Maddrey WC, Mizokami M, Seto WK, Zoulim F, Lai CL.
J Clin Gastroenterol. 2016 Apr;50(4):286-94. doi: 10.1097/MCG.0000000000000478.
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
Bazinet M, Pântea V, Cebotarescu V, Cojuhari L, Jimbei P, Anderson M, Gersch J, Holzmayer V, Elsner C, Krawczyk A, Kuhns MC, Cloherty G, Dittmer U, Vaillant A.
Hepatol Commun. 2020 Nov 13;5(2):189-202. doi: 10.1002/hep4.1633. eCollection 2021 Feb.
